neostigmine has been researched along with Morbid Obesity in 8 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Excerpt | Relevance | Reference |
---|---|---|
"Prospective observational series of consecutive patients scheduled for laparoscopic bariatric surgery in whom neuromuscular blockade was reverted with sugammadex were compared with a historical matched cohort of patients reverted with neostigmines." | 7.80 | Postoperative respiratory outcomes in laparoscopic bariatric surgery: comparison of a prospective group of patients whose neuromuscular blockade was reverted with sugammadex and a historical one reverted with neostigmine. ( Cabrera, A; Camprubí, I; Ferreres, E; Llauradó, S; Sabaté, A, 2014) |
" We evaluated the role of sugammadex versus neostigmine in the quality of recovery from profound rocuronium-induced neuromuscular blockade (NMB) in patients with morbid obesity." | 5.17 | Sugammadex allows fast-track bariatric surgery. ( Carron, M; Foletto, M; Ori, C; Veronese, S, 2013) |
" In the patient described in this article, heart block occurred and the Q-Tc interval became prolonged after muscle relaxant reversal with neostigmine; both were considered to be related to the combination of agents used in the case, as well as to other predisposing factors such as morbid obesity." | 4.84 | Heart block and prolonged Q-Tc interval following muscle relaxant reversal: a case report. ( Shields, JA, 2008) |
"Prospective observational series of consecutive patients scheduled for laparoscopic bariatric surgery in whom neuromuscular blockade was reverted with sugammadex were compared with a historical matched cohort of patients reverted with neostigmines." | 3.80 | Postoperative respiratory outcomes in laparoscopic bariatric surgery: comparison of a prospective group of patients whose neuromuscular blockade was reverted with sugammadex and a historical one reverted with neostigmine. ( Cabrera, A; Camprubí, I; Ferreres, E; Llauradó, S; Sabaté, A, 2014) |
"However, the effect of this agent in postoperative pain is still unknown." | 2.79 | Sugammadex reduces postoperative pain after laparoscopic bariatric surgery: a randomized trial. ( Borges, S; Castro, DS; Figueiredo, P; Gomes, L; Leão, P; Pacheco, M, 2014) |
" Consequently, incorrect dosing will increase the rate of perioperative complications." | 2.46 | Perioperative pharmacology in morbid obesity. ( Lemmens, HJ, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carron, M | 2 |
Veronese, S | 1 |
Foletto, M | 1 |
Ori, C | 2 |
Llauradó, S | 1 |
Sabaté, A | 1 |
Ferreres, E | 1 |
Camprubí, I | 1 |
Cabrera, A | 1 |
Castro, DS | 1 |
Leão, P | 1 |
Borges, S | 1 |
Gomes, L | 1 |
Pacheco, M | 1 |
Figueiredo, P | 1 |
Lemmens, HJ | 1 |
Gaszynski, T | 1 |
Szewczyk, T | 1 |
Gaszynski, W | 1 |
Parotto, E | 1 |
Schumann, R | 1 |
Tarnoff, M | 1 |
Siddiqui, ZI | 1 |
Shields, JA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Comparing Deep Neuromuscular Block and Moderate Neuromuscular Block in Patients Undergoing Laparoscopic Gynaecological Surgeries: Impact on Surgical Satisfaction of Operating Conditions and Patient Satisfaction[NCT02794714] | Phase 4 | 0 participants (Actual) | Interventional | 2016-06-30 | Withdrawn (stopped due to unresolved budget issues) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for neostigmine and Morbid Obesity
Article | Year |
---|---|
Perioperative pharmacology in morbid obesity.
Topics: Analgesics, Opioid; Anesthetics; Anesthetics, Inhalation; Animals; Body Mass Index; Body Weight; Cho | 2010 |
Heart block and prolonged Q-Tc interval following muscle relaxant reversal: a case report.
Topics: Adjuvants, Anesthesia; Adult; Anesthesia, Inhalation; Anesthesia, Intravenous; Anesthetics, Inhalati | 2008 |
3 trials available for neostigmine and Morbid Obesity
Article | Year |
---|---|
Sugammadex allows fast-track bariatric surgery.
Topics: Adult; Anesthesia Recovery Period; Bariatric Surgery; Female; gamma-Cyclodextrins; Humans; Male; Mid | 2013 |
Sugammadex reduces postoperative pain after laparoscopic bariatric surgery: a randomized trial.
Topics: Adult; Bariatric Surgery; Female; gamma-Cyclodextrins; Humans; Laparoscopy; Male; Neostigmine; Obesi | 2014 |
Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia.
Topics: Adult; Androstanols; Anesthesia Recovery Period; Anthropometry; Bariatric Surgery; gamma-Cyclodextri | 2012 |
3 other studies available for neostigmine and Morbid Obesity
Article | Year |
---|---|
Postoperative respiratory outcomes in laparoscopic bariatric surgery: comparison of a prospective group of patients whose neuromuscular blockade was reverted with sugammadex and a historical one reverted with neostigmine.
Topics: Adult; Aged; Bariatric Surgery; Cholinesterase Inhibitors; Female; gamma-Cyclodextrins; Humans; Lapa | 2014 |
Prolonged neuromuscular block associated to non-alcoholic steatohepatitis in morbidly obese patient: neostigmine versus sugammadex.
Topics: Adult; Biopsy; Cholinesterase Inhibitors; Fatty Liver; gamma-Cyclodextrins; Humans; Male; Monitoring | 2012 |
Minimally invasive gastric bypass in a morbidly obese patient with myasthenia gravis.
Topics: Anesthesia, Inhalation; Anesthetics, Local; Cholinesterase Inhibitors; Comorbidity; Female; Gastric | 2004 |